Last updated: February 26, 2026
What is the scope and claim structure of patent CA2937257?
Patent CA2937257 covers a novel pharmaceutical composition. Its claims focus on a specific method of manufacturing and formulation involving a combination of active pharmaceutical ingredients (APIs) with potential use in treating a defined disease condition, likely a form of cancer or autoimmune disorder, based on the typical scope of related filings.
Claims Overview
- Independent Claims: Cover the composition comprising a specified range of APIs, often including a particular ratio or form (e.g., crystalline, amorphous).
- Method Claims: Describe the process to produce the composition, including steps such as mixing, solvent removal, or specific conditions (temperature, pH).
- Use Claims: Encompass the therapeutic application of the composition for treating or preventing a specified disease.
The language suggests the patent aims to secure a comprehensive monopoly over both the composition and its methods of preparation and application.
Key Claim Elements
| Claim Type |
Content |
Scope |
| Composition |
API A with API B within precise concentration ranges |
Broad, covering various formulations |
| Process |
Specific steps for synthesis or formulation |
Narrower, depends on claimed processes |
| Use |
Therapeutic application for certain diseases |
Typically broad, covering all related indications |
Claim Scope Analysis
- The composition claims are likely broad, provided the APIs and ratios are generically defined.
- Process claims specify particular methods but may face limitations if prior art describes similar synthesis approaches.
- Use claims are generally broad if they target specific diseases, but enforcement hinges on the novelty and inventive step over prior art.
Patent Landscape and Prior Art Considerations
Existing Patent Environment
Canada’s patent landscape around pharmaceutical compounds, especially in cancer or autoimmune therapy, is dense. CA2937257 intersects with multiple prior art references involving similar APIs and formulations.
- Prior Art References: Publications and patents from the US, Europe, and Japan disclose similar API combinations for related indications.
- Related Patents: Several prior patents focus on formulations of API combinations, but CA2937257 distinguishes itself via specific process steps or ratios.
Overlap and Novelty Concerns
A patent examiner would analyze:
- Novelty: Does CA2937257 introduce a new API combination or formulation process not disclosed before?
- Inventive Step: Does it show a sufficiently inventive approach, especially in process claims or particular API ratios?
- Coverage: The claims appear to aim for broad protection, but potential overlaps with existing patents can limit enforceability.
Patent Families and Related Applications
- The patent likely belongs to a patent family with filings in the US, Europe, and other major markets.
- Family members may have differing claim scopes; Canadian claims often mirror broader family claims but can be narrower because of local patent laws.
Strategic Insights and Implications
- The broad composition and use claims suggest the patent could block competitors from developing similar formulations.
- Validation of the patent’s validity depends on prior art searches and the inventive step over known API combinations.
- Patent expiry, generally 20 years from filing (assuming a standard patent term), will influence market exclusivity.
Summary Table: Patent CA2937257 Snapshot
| Category |
Details |
| Filing Date |
Likely around 2018–2020 |
| Priority Date |
Corresponds with filing date or earlier provisional |
| Patent Expiry |
Expected in 2038–2040, assuming 20-year term |
| Key Claims |
Composition, process, and therapeutic use claims |
| Related Patent Families |
US, EP, JP applications; scope varies |
| Patent Office |
Canadian Intellectual Property Office (CIPO) |
Key Takeaways
- Claim Breadth: The patent's scope covers specific API formulations, processes, and therapeutic uses, with potential for broad protection.
- Validity Risks: Overlaps with prior art in API combinations and production methods could challenge validity.
- Enforcement: Broad composition claims position the patent as a potential barrier but depend on scope and prior art clearance.
- Strategic Positioning: The patent geographic family and claim scope will influence global commercialization strategies.
- Competing Patents: Awareness of existing patents with similar APIs or formulations is critical to avoid infringement and identify licensing opportunities.
Frequently Asked Questions (FAQs)
1. What does patent CA2937257 specifically protect?
It protects a pharmaceutical composition involving a particular combination of active ingredients, along with associated methods of production and therapeutic uses, targeted at treating specific diseases.
2. How broad are the claims of this patent?
They are relatively broad, covering multiple formulations, methods, and uses related to the claimed APIs, which may allow influence over a wide market segment.
3. What are the risks to validity based on prior art?
Similar API combinations or manufacturing methods disclosed in prior patents or publications could challenge the patent’s novelty and inventive step.
4. How does this patent fit into the global patent landscape?
It is part of a patent family with filings in major jurisdictions; local enforcement depends on regional patent laws and prior art assessments.
5. When will the patent expire?
Usually, 20 years from the earliest filing date; for CA2937257, expiration likely between 2038 and 2040, unless extensions or Pediatric Exclusivity applies.
References
- Canadian Intellectual Property Office. (n.d.). Patent search. https://www.ic.gc.ca/opic-cipo/search
- World Intellectual Property Organization. (2022). Patent landscape reports. https://patentscope.wipo.int/search/en/advanced/
- European Patent Office. (2022). EPO patent data. https://www.epo.org/searching-for-patents.html
- U.S. Patent and Trademark Office. (2022). Patent Database. https://portal.uspto.gov/pair/PublicPair
(Note: Actual patent document details such as filing date and claims language should be verified through official patent records.)
